Table 2 Diffuse melanoma related mortality.
| Interval | Kaplan‐Meier survival | |
|---|---|---|
| Estimate | 95% CI | |
| 5 year | 93.30% | (61.3% to 99.0%) |
| 10 year | 84.80% | (51.2% to 96.0%) |
| 15 year | 70.70% | (30.6% to 90.3%) |
| 20 year | 70.70% | (30.6% to 90.3%) |
| Interval | Kaplan‐Meier survival | |
|---|---|---|
| Estimate | 95% CI | |
| 5 year | 93.30% | (61.3% to 99.0%) |
| 10 year | 84.80% | (51.2% to 96.0%) |
| 15 year | 70.70% | (30.6% to 90.3%) |
| 20 year | 70.70% | (30.6% to 90.3%) |